In this hard-hitting interview on Man In America, host Seth Holehouse sits down with Kim Bright of Brightcore Nutrition to pull back the curtain on GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. Marketed as miracle weight-loss solutions, these injections are now linked to over 3,500 (and climbing) federal lawsuits involving severe gastrointestinal issues, stomach paralysis (gastroparesis), bowel obstruction, sudden vision loss, organ failure, mood disorders, hair loss, and even deaths—with the FDA accusing manufacturers of underreporting fatalities. Real patient stories, like one woman who lost part of her intestine and nearly died, highlight the dangers, while the conversation dives into how these drugs disrupt the gut microbiome and natural healing processes, contrasting them with centuries-old natural approaches to sustainable health.
